Solving the challenges of Leachable pharmaceutical impurities using a full analytical portfolio
Extractables and leachable compounds are a complex and ever growing list of pharmaceutical impurities
Stephen Guilfoyle |
Stephen Guilfoyle (Pharma & Biopharma Marketing, Thermo Fisher Scientific) discusses developments in the regulatory landscape and a broad portfolio of tools to meet these challenges. Find out more about Extractables & Leachables testing at http://www.thermoscientific.com/en/community/extractables-leachables.html?ca=Leachables
Read the full article now
Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Analytical Scientist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.